halofantrine has been researched along with lumefantrine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
| Masseno, V; Muriithi, S; Nzila, A | 1 |
| Sen, S; Sinha, N | 1 |
| Avery, VM; Buchholz, M; Delves, MJ; Duffy, S; Fischli, C; Held, J; Knaab, TC; Kuna, K; Kurz, T; Lehmann, U; Leven, M; Lungerich, B; Meister, S; Meitzner, D; Mordmüller, B; Stahlke, P; Winzeler, EA; Wittlin, S | 1 |
| Go, ML; Li, QT | 1 |
| Fidock, DA; Krishna, S; Sidhu, AB; Uhlemann, AC; Valderramos, JC; Valderramos, SG | 1 |
| Jain, GK; Singh, SP | 1 |
| Abildrup, U; Alifrangis, LH; Alifrangis, M; Bygbjerg, IC; Hoegberg, L; Khalil, IF; Lemnge, MM; Maiga, D; Nyagonde, N; Persson, OP; Theander, TG; Vestergaard, LS | 1 |
| Angelino, E; Barnes, KG; Becker, JS; Birren, BW; Cortese, JF; Daniels, RF; Eskin, E; Furlotte, NA; Grossman, SR; Happi, C; Hartl, DL; Johnson, CA; Kang, HM; Karlsson, EK; Lander, ES; Lukens, AK; Mboup, S; Milner, DA; Ndiaye, D; Neafsey, DE; Park, DJ; Rosen, DM; Sabeti, PC; Sarr, O; Schaffner, SF; Shlyakhter, I; Van Tyne, D; Volkman, SK; Wiegand, RC; Wirth, DF; Yamins, D | 1 |
| Cowman, AF; Healer, J; Uboldi, AD; Van Tyne, D; Wirth, DF | 1 |
| Gayen, JR; Raju, KS; Siddiqui, HH; Singh, SK; Singh, SP; Taneja, I; Wahajuddin, M | 1 |
| Raju, KS; Singh, SP; Taneja, I; Wahajuddin, M | 1 |
| Be Rziņš, KR; Beilles, S; Boyd, BJ; Clulow, AJ; Fraser-Miller, SJ; Gordon, KC; Hawley, A; Ramirez, G; Salim, M; Sutton, JJ | 1 |
13 other study(ies) available for halofantrine and lumefantrine
| Article | Year |
|---|---|
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
In vitro chemosensitization of Plasmodium falciparum to antimalarials by verapamil and probenecid.
Topics: Adjuvants, Pharmaceutic; Animals; Antimalarials; Parasitic Sensitivity Tests; Plasmodium falciparum; Probenecid; Verapamil | 2009 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
3-Hydroxy-N'-arylidenepropanehydrazonamides with Halo-Substituted Phenanthrene Scaffolds Cure P. berghei Infected Mice When Administered Perorally.
Topics: Amides; Animals; Antimalarials; Hep G2 Cells; Humans; Hydrazones; Malaria; Mice; Phenanthrenes; Plasmodium berghei; Stereoisomerism; Structure-Activity Relationship | 2017 |
Interaction of the antimalarial agents halofantrine and lumefantrine with lipid bilayers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antimalarials; Erythrocyte Membrane; Ethanolamines; Fluorenes; Lipid Bilayers; Lumefantrine; Male; Mice; Phenanthrenes; Phosphatidylcholines | 2003 |
Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.
Topics: Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; DNA, Protozoan; Drug Resistance, Multiple; Ethanolamines; Fluorenes; Genes, MDR; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Quinine; Sesquiterpenes | 2006 |
Determination of lumefantrine in rat plasma by liquid-liquid extraction using LC-MS/MS with electrospray ionization: assay development, validation and application to a pharmacokinetic study.
Topics: Animals; Antimalarials; Calibration; Chromatography, High Pressure Liquid; Ethanolamines; Fluorenes; Indicators and Reagents; Lumefantrine; Male; Phenanthrenes; Rats; Rats, Sprague-Dawley; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2009 |
Measurement of lumefantrine and its metabolite in plasma by high performance liquid chromatography with ultraviolet detection.
Topics: Acetates; Artemether; Artemisinins; Calibration; Chemistry Techniques, Analytical; Chromatography; Chromatography, High Pressure Liquid; Ethanolamines; Fluorenes; Hexanes; Kinetics; Lumefantrine; Models, Chemical; Phenanthrenes; Regression Analysis; Reproducibility of Results; Spectrophotometry, Ultraviolet; Ultraviolet Rays | 2011 |
Identification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparum.
Topics: Antimalarials; Drug Resistance; Ethanolamines; Fluorenes; Gene Dosage; Gene Expression; Genetic Association Studies; Genetic Loci; Genetic Variation; Genotype; Haplotypes; Linkage Disequilibrium; Lumefantrine; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Polymorphism, Single Nucleotide; Selection, Genetic | 2011 |
Modulation of PF10_0355 (MSPDBL2) alters Plasmodium falciparum response to antimalarial drugs.
Topics: Antimalarials; Base Sequence; DNA Copy Number Variations; Drug Resistance; Ethanolamines; Fluorenes; Gene Dosage; Gene Frequency; Genes, Protozoan; Lumefantrine; Malaria, Falciparum; Mefloquine; Mutation; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Sequence Analysis, DNA | 2013 |
Simultaneous quantification of proposed anti-malarial combination comprising of lumefantrine and CDRI 97-78 in rat plasma using the HPLC-ESI-MS/MS method: application to drug interaction study.
Topics: Animals; Antimalarials; Blood Chemical Analysis; Bridged Bicyclo Compounds, Heterocyclic; Chromatography, High Pressure Liquid; Drug Combinations; Ethanolamines; Fluorenes; Lumefantrine; Male; Phenanthrenes; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2015 |
Assessment of pharmacokinetic compatibility of short acting CDRI candidate trioxane derivative, 99-411, with long acting prescription antimalarials, lumefantrine and piperaquine.
Topics: Animals; Antimalarials; Chromatography, High Pressure Liquid; Ethanolamines; Fluorenes; Half-Life; Heterocyclic Compounds; Humans; Lumefantrine; Microsomes, Liver; Phenanthrenes; Quinolines; Rats; Spiro Compounds; Tandem Mass Spectrometry | 2015 |
Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion.
Topics: Administration, Oral; Aminoquinolines; Animals; Biological Availability; Clofazimine; Digestion; Drug Compounding; Drug Delivery Systems; Ferrous Compounds; Infant Formula; Lipolysis; Lumefantrine; Metallocenes; Milk; Phenanthrenes; Scattering, Small Angle; Solubility; Spectrum Analysis, Raman; Suspensions; Water; X-Ray Diffraction | 2020 |